サマリー

The global chondroitin sulfate market grew at a CAGR of around 4% during 2015-2020. Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C6H13NO5) is anti-atherogenic, inflammatory, thrombogenic and assists in the performance of coagulant activities. Consequently, it is utilized in oral delivery of insulin, proteins and peptides and as a skin substitute and biomaterial for wound healing in the healthcare sector.

CS acts as a precursor for inhibiting degradation, stimulating synthesis and improving the healing of articular cartilage. This represents one of the primary factors escalating the demand for CS-based injectable hydrogels in cartilage tissue engineering for fabricating purposes. Moreover, as it is an enzymatically biodegradable polysaccharide and has high water solubility and lack of mechanical stability, CS is modified with materials like collagen to be utilized in scaffold matrices and other drug delivery applications. Furthermore, it is being used in dietary supplements for relieving pain and disability of individuals with musculoskeletal pathologies or osteoarthritis. In line with this, CS serves as a template for generating hydroxyapatite nanocrystals, thereby contributing to the market growth. It is also gaining traction as an antistatic agent in the cosmetics industry for manufacturing hair conditioning products. However, the surging cases of the coronavirus disease (COVID-19), the imposition of lockdown restrictions in various countries and subsequent halt in the manufacturing units are anticipated to hinder the market growth. The market will experience growth on account of the growing access to healthcare services and the introduction of innovative CS products. Looking forward, IMARC Group expects the global chondroitin sulfate market to continue its moderate growth during the next five years.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global chondroitin sulfate market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, source, form and application.

Breakup by Source:

Bovine
Swine
Poultry
Shark
Others

Breakup by Form:

Powder
Tablet
Others

Breakup by Application:

Pharmaceuticals and Nutraceuticals
Animal Feed
Personal Care and Cosmetics
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioiberica S.A.U., BRF S.A., HeBei SanXin Industrial Group, Maypro Industries Inc., Merck KGaA, Pacific Rainbow International Inc., Qingdao Wantuming Biological Products Co. Ltd., Seikagaku Corporation, Sino Siam Biotechnique Company Limited, Sioux Pharm Inc., Synutra International Inc. and ZPD A/S.

Key Questions Answered in This Report:
How has the global chondroitin sulfate market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global chondroitin sulfate market?
What are the key regional markets?
What is the breakup of the market based on the source?
What is the breakup of the market based on the form?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global chondroitin sulfate market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Chondroitin Sulfate Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Source
6.1 Bovine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Swine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Poultry
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Shark
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Form
7.1 Powder
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Tablet
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Pharmaceuticals and Nutraceuticals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Animal Feed
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Personal Care and Cosmetics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Bioiberica S.A.U.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 BRF S.A.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 HeBei SanXin Industrial Group
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Maypro Industries Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Merck KGaA
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Pacific Rainbow International Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Qingdao Wantuming Biological Products Co. Ltd.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Seikagaku Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.9 Sino Siam Biotechnique Company Limited
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sioux Pharm Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Synutra International Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 ZPD A/S
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio